Pentavalent 3

The Pentavalent 3 vaccine is given to infants at 14 weeks of age as part of the routine immunization schedule. This combination vaccine protects against five serious diseases: Diphtheria, Pertussis (whooping cough), Tetanus, Hepatitis B, and Haemophilus influenzae type B (Hib). Administered as a 0.5 ml intramuscular injection in the antero-lateral thigh, it provides long-lasting immunity and completes the primary series of Pentavalent vaccines. Pentavalent 3 is crucial for ensuring comprehensive protection and preventing the spread of these potentially life-threatening infections in young children.